Effect of TGZ on plasma adiponectin level in humans. Effects of TGZ on human plasma adiponectin levels were studied in 29
mildly overweight subjects with glucose intolerance. The subjects were divided randomly into three groups: placebo group (n = 8), TGZ 200 mg/day group (n = 10), and TGZ 400 mg/day group (n = 11). Each group was treated with the indicated amount of TGZ for 12 weeks. Data are represented as percentage change relative
to the mean levels before the treatment. Values are means ± SE.